S&P・Nasdaq 本質的価値 お問い合わせ

Alvotech ALVOW NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IS • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
$76.24
+29223.1%

Alvotech (ALVOW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-0.13 および 売上高 $0.45B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-0.87 vs 予想 $-0.13 (下回る -593.3%). 2025: 実績 $0.10 vs 予想 $-0.08 (上回る +223.1%). アナリスト精度: 0%.

EPS予測 — ALVOW

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.87 vs Est –$0.13 ▼ 85.6% off
2025 Actual $0.10 vs Est –$0.08 ▲ 181.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

売上高予測 — ALVOW

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.490B vs Est $0.454B ▲ 7.2% off
2025 Actual $0.586B vs Est $0.581B ▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る